Mutant enrichment with 3'-modified oligonucleotides a practical PCR method for detecting trace mutant DNAs

Area of Science:

• Molecular Biology
• Genetics
• Biotechnology

Background:

• Clinical molecular assays require high sensitivity and reliability, which are often limited by current testing methods.
• Detecting specific genetic mutations is crucial for diagnosing and managing diseases, particularly cancer.

Purpose of the Study:

• To introduce a novel, cost-effective enrichment technique named mutant enrichment with 3 -modified oligonucleotides (MEMO).
• To evaluate the performance of MEMO in detecting common cancer mutations across multiple genes.

Main Methods:

• MEMO utilizes a 3 -modified oligonucleotide primer designed to block normal allele extension while permitting mutated allele extension.
• The technique was tested for its ability to detect mutations in EGFR, KRAS, BRAF, TP53, JAK2, and NPM1 genes.
• Sensitivity was assessed using downstream Sanger sequencing.

Main Results:

• The MEMO technique achieved detection sensitivities ranging from 10(-2) to 10(-6), contingent on primer concentrations and thermodynamics.
• Successful detection of common cancer mutations was demonstrated across a panel of key genes.

Conclusions:

• MEMO offers a simple, inexpensive, and effective method for enriching mutant DNA, thereby enhancing molecular assay sensitivity.
• This technique shows potential for broad applicability in various medical diagnostics, including quantitative real-time PCR and other downstream assays.